Amphastar Pharmaceuticals Inc (FRA:29A)
€ 39.36 0 (0%) Market Cap: 1.89 Bil Enterprise Value: 2.20 Bil PE Ratio: 14.97 PB Ratio: 3.14 GF Score: 71/100

Q4 2019 Amphastar Pharmaceuticals Inc Earnings Call Transcript

Mar 12, 2020 / 09:00PM GMT
Release Date Price: €13.4 (-0.74%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Amphastar Fourth Quarter Earnings Call. (Operator Instructions)

I will now say some forward-looking statements. All statements on this conference call that are not historical are forward-looking statements, including, among other things, statements relating to the company's expectations regarding future financial performance, backlog, sales and marketing of its products; market size and growth; the timing of the FDA filings or approvals, including the DMF of ANP; the timing of product launches, acquisitions and other materials related to its pipeline of product candidates; its share buyback program and other future events. These statements are not historical facts, but rather are based on Amphastar's historical performance and its current expectations, estimates and projections regarding Amphastar's business operations and other similar or related factors. Words such as may, might, will, could, would, should, anticipate, predict, potential, continue, expect, intend, plan, project, believe, estimate and other similar or related

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot